Literature DB >> 29111233

Age and immunity: What is "immunosenescence"?

Graham Pawelec1.   

Abstract

As is apparent from the many contributions to this Special Issue of the Journal, the impact of age on immunity is nefarious, with all manner of dysregulated responses attributed to "immunosenescence". These range from poorer responses to vaccination, lower capacity to mediate anti-cancer responses, more inflammation and tissue damage, along with autoimmunity and loss of control of persistent infections. Given the grave clinical implications of altered immune status in aged people, it is of paramount importance to understand the nature of and mechanisms responsible for "immunosenescence". As in any rapidly developing research area, certain paradigms establish themselves early on, by necessity based on earlier and fewer data, and have a disproportionate influence on how investigators think about the subject, especially investigators from other disciplines. It may therefore be appropriate to reconsider our basic knowledge at this juncture, asking exactly what do we mean by the term "immunosenescence"? This is attempted in this contribution to the Special Issue.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29111233     DOI: 10.1016/j.exger.2017.10.024

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  107 in total

1.  Multi-color flow cytometry for evaluating age-related changes in memory lymphocyte subsets in dogs.

Authors:  Sita S Withers; Peter F Moore; Hong Chang; Jin W Choi; Stephen J McSorley; Michael S Kent; Arta M Monjazeb; Robert J Canter; William J Murphy; Ellen E Sparger; Robert B Rebhun
Journal:  Dev Comp Immunol       Date:  2018-05-31       Impact factor: 3.636

2.  Aging-related tumor associated fibroblasts changes could worsen the prognosis of GBM patients.

Authors:  Hongwang Song; Xiaojun Fu; Chenxing Wu; Shouwei Li
Journal:  Cancer Cell Int       Date:  2020-10-08       Impact factor: 5.722

Review 3.  Immunosenescence: a key player in cancer development.

Authors:  Jingyao Lian; Ying Yue; Weina Yu; Yi Zhang
Journal:  J Hematol Oncol       Date:  2020-11-10       Impact factor: 17.388

Review 4.  Bloodstream infections in the elderly: what is the real goal?

Authors:  Yaara Leibovici-Weissman; Noam Tau; Dafna Yahav
Journal:  Aging Clin Exp Res       Date:  2019-09-05       Impact factor: 3.636

5.  Harvard HIV and Aging Workshop: Perspectives and Priorities from Claude D. Pepper Centers and Centers for AIDS Research.

Authors:  Monty Montano; Shalender Bhasin; Richard T D'Aquila; Kristine M Erlandson; William J Evans; Nicholas T Funderburg; Amy Justice; Lishomwa C Ndhlovu; Bisola Ojikutu; Marco Pahor; Savita Pahwa; Alice S Ryan; Jennifer Schrack; Michael B Schultz; Paola Sebastiani; David A Sinclair; Julia Tripp; Bruce Walker; Julie A Womack; Raymond Yung; R Keith Reeves
Journal:  AIDS Res Hum Retroviruses       Date:  2019-09-23       Impact factor: 2.205

6.  Efficacy and safety of immune checkpoint inhibitor immunotherapy in elderly cancer patients.

Authors:  B Fox; M de Toro Carmena; R Álvarez Álvarez; A Calles Blanco; C López López; S Pérez Ramírez; J Á Arranz; M Martín; I Márquez-Rodas
Journal:  Clin Transl Oncol       Date:  2019-06-29       Impact factor: 3.405

Review 7.  Does patient age influence anti-cancer immunity?

Authors:  Graham Pawelec
Journal:  Semin Immunopathol       Date:  2018-07-13       Impact factor: 9.623

8.  Immunogenicity and predictors of response to a single dose trivalent seasonal influenza vaccine in multiple sclerosis patients receiving disease-modifying therapies.

Authors:  Christoph Metze; Alexander Winkelmann; Micha Loebermann; Michael Hecker; Brunhilde Schweiger; Emil Christian Reisinger; Uwe Klaus Zettl
Journal:  CNS Neurosci Ther       Date:  2018-07-25       Impact factor: 5.243

9.  Impact of trial design and patient heterogeneity on the identification of clinically effective therapies for progressive MS.

Authors:  Elizabeth A Mills; Joel A Begay; Caitlyn Fisher; Yang Mao-Draayer
Journal:  Mult Scler       Date:  2018-10-10       Impact factor: 6.312

Review 10.  Mechanisms underlying T cell ageing.

Authors:  Jörg J Goronzy; Cornelia M Weyand
Journal:  Nat Rev Immunol       Date:  2019-06-11       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.